At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 84 enrolled
Drug / intervention
MT-1186 +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study)
In Brief
A Phase 1 clinical trial evaluating MT-1186, Rosuvastatin, and 2 other interventions for Healthy Adult Subjects. Completed, enrolled 84 participants across 1 site.
Detailed Summary
* Cohort 1: To evaluate the drug interactions, safety, and tolerability of oral edaravone when coadministered with rosuvastatin, sildenafil or furosemide in healthy adult males * Cohort 2: To evaluate the pharmacokinetics, safety, and tolerability of oral edaravone in healthy Japanese and Caucasian adult males
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Adult Subjects
CountriesJapan
Collaborators--
Timeline
Phase 1CompletedFinished
20192020202120222023202420252026
Enrollment StartOct 2018
Primary CompletionDec 2018
Study CompletionJan 2019
First PostedJul 2020
TodayJul 2026
First PostedJul 22, 2020
Enrollment StartOct 17, 2018
Primary CompletionDec 20, 2018
Study CompletionJan 8, 2019
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 5.9 years ago
Interventions
MT-1186drug
Suspension
Rosuvastatindrug
Tablets
Sildenafildrug
Tablets
Furosemidedrug
Tablets